Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended	9 Months Ended
Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Total revenues	$ 293.8	$ 270.5	$ 848.9	$ 772.7
Operating expenses:
Cost of goods and services sold	122.6	176.8	563.3	520.3
Research and development	13.8	15.3	61.6	82.0
Selling, general and administrative	76.6	86.0	247.2	278.7
Amortization of intangible assets	16.3	16.3	48.8	49.4
Goodwill impairment	0.0	218.2	0.0	218.2
Impairment of long-lived assets	0.0	0.0	27.2	306.7
Total operating expenses	229.3	512.6	948.1	1,455.3
Income (loss) from operations	64.5	(242.1)	(99.2)	(682.6)
Other income (expense):
Interest expense	(8.3)	(19.7)	(56.2)	(66.2)
Gain (loss) on sale of business	64.3	(0.7)	24.3	74.2
Other, net	21.9	(3.4)	15.8	(2.1)
Total other income (expense), net	77.9	(23.8)	(16.1)	5.9
Income (loss) before income taxes	142.4	(265.9)	(115.3)	(676.7)
Income tax provision (benefit)	27.6	(2.5)	44.0	34.3
Net income (loss)	$ 114.8	$ (263.4)	$ (159.3)	$ (711.0)
Earnings (loss) per common share
Basic (in dollars per share)	$ 2.16	$ (5.08)	$ (3.03)	$ (13.97)
Diluted (in dollars per share)	$ 2.06	$ (5.08)	$ (3.03)	$ (13.97)
Weighted average shares outstanding
Basic (in shares)	53.1	51.8	52.6	50.9
Diluted (in shares)	55.6	51.8	52.6	50.9
Total Product sales, net
Revenues:
Product sales	$ 269.5	$ 249.8	$ 726.8	$ 695.4
Commercial Product sales
Revenues:
Product sales	95.3	142.1	333.8	386.2
Operating expenses:
Cost of goods and services sold	47.2	60.0	152.7	160.2
MCM Product sales
Revenues:
Product sales	174.2	107.7	393.0	309.2
Operating expenses:
Cost of goods and services sold	54.0	72.5	147.3	208.4
Total Bioservices revenues
Revenues:
Total Bioservices revenues	14.3	14.2	97.5	57.7
Operating expenses:
Cost of goods and services sold	21.4	44.3	263.3	151.7
Services
Revenues:
Product sales	13.9	13.2	96.7	52.2
Leases
Revenues:
Leases	0.4	1.0	0.8	5.5
Contracts and grants
Revenues:
Product sales	$ 10.0	$ 6.5	$ 24.6	$ 19.6

Operating Lease, Lease Income And Revenue From Contract With Customer, Excluding Assessed Tax

No definition available.

Name:	ebs_OperatingLeaseLeaseIncomeAndRevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix:	ebs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.